#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Inborn error of metabolism Breast cancer Advanced systemic mastocytosis Pleomorphic liposarcoma Hidradenitis Oropharyngeal squamous cell carcinoma Solitary fibrous tumour Pyruvate dehydrogenase complex deficiency Myotonic dystrophy Small cell lung cancer recurrent Brain injury B-cell small lymphocytic lymphoma Von Hippel-Lindau disease Indolent systemic mastocytosis Colitis ulcerative More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis II – Treatment Haemophilia A with anti factor VIII – Trials in Disease Netherton’s syndrome – Life with Disease Congenital generalised lipodystrophy – Basic Information Hyperoxaluria Testicular leiomyosarcoma Progressive multifocal leukoencephalopathy – Life with Disease Langerhans’ cell histiocytosis – Life with Disease Chondrosarcoma – Diagnostics Piriformis syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Esomeprazole Lonapegsomatropin Cdr132L Bi 706321 Osimertinib ILOPROST Efmoroctocog Alfa Soya Oil, Purified Cloxacillin Sodium Desloratadine Fosaprepitant Tumor Necrosis Factor-Alpha Azacitidine Dipyridamole Ciclesonide Metformin Hydrochloride Omo-103 Empasiprubart Pervi-Neo Ucp2 More therapies…

    Learn about Your Condition

    Behcet's syndrome Pulmonary sarcoidosis Migraine Iron overload Neuroblastoma Breast cancer female Glycogen storage disorder Abdominal pain Cervix carcinoma Skin disorder Chronic kidney disease Malignant fibrous histiocytoma Trigeminal neuralgia Acute myeloid leukaemia Premature rupture of membranes More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Dinutuximab Beta and Drug Combination for Children, Teens, and Adults with GD2-Positive Ewing Sarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Dinutuximab Beta
    • Mesna
    • Filgrastim
    Austria Czechia Germany Sweden

  • Study on the Safety and Effects of YTB323, Tocilizumab, and Cyclophosphamide in Patients with Relapsing Multiple Sclerosis Who Have Active Disease Despite Treatment

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Cyclophosphamide
    • Fludarabine Phosphate
    • Rapcabtagene Autoleucel
    France Germany Italy Spain

  • Study on the Safety of Anti-GD2 CAR T Cells, Cyclophosphamide, and Fludarabine in Children and Young Adults with Relapsed or Refractory Brain Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant central nervous system neoplasm
    Investigated Drugs:
    • AUTOLOGOUS T CELLS TRANSDUCED WITH A RETROVIRAL VECTOR ENCODING A CHIMERIC ANTIGEN RECEPTOR AGAINST GD2, EX-VIVO EXPANDED
    • RIMIDUCID
    • Cyclophosphamide
    Italy

  • Study of iG-Tregs for Preventing Graft-versus-Host Disease in Adults Undergoing HLA-Matched Sibling Stem Cell Transplantation

    Recruiting

    1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • IG-TREGS
    Greece

  • Study on Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa Using Skin Grafts with Genetically Corrected Autologous Keratinocytes and Fibroblasts

    Recruiting

    2 1 1
    Investigated Diseases:
    • Epidermolysis bullosa
    Investigated Drugs:
    • AUTOLOGOUS KERATINOCYTES AND FIBROBLASTS TRANSDUCED WITH A RETROVIRAL VECTOR ENCODING COL7A1 CDNA
    France

  • Study on Indapamide for Patients with Chronic Post-Surgical Hypoparathyroidism

    Recruiting

    3 1 1
    Investigated Drugs:
    • INDAPAMIDE HEMIHYDRATE
    Denmark
Previous Page
1 … 242 243 244 245 246 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!